195 related articles for article (PubMed ID: 11008904)
1. Serum selenium and subsequent risk of prostate cancer.
Nomura AM; Lee J; Stemmermann GN; Combs GF
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):883-7. PubMed ID: 11008904
[TBL] [Abstract][Full Text] [Related]
2. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk.
Goodman GE; Schaffer S; Bankson DD; Hughes MP; Omenn GS;
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1069-76. PubMed ID: 11588133
[TBL] [Abstract][Full Text] [Related]
3. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study.
van den Brandt PA; Zeegers MP; Bode P; Goldbohm RA
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):866-71. PubMed ID: 14504196
[TBL] [Abstract][Full Text] [Related]
4. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.
Männistö S; Pietinen P; Virtanen MJ; Salminen I; Albanes D; Giovannucci E; Virtamo J
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1422-8. PubMed ID: 14693732
[TBL] [Abstract][Full Text] [Related]
5. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
Goodman GE; Schaffer S; Omenn GS; Chen C; King I
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
[TBL] [Abstract][Full Text] [Related]
6. Plasma selenium level before diagnosis and the risk of prostate cancer development.
Brooks JD; Metter EJ; Chan DW; Sokoll LJ; Landis P; Nelson WG; Muller D; Andres R; Carter HB
J Urol; 2001 Dec; 166(6):2034-8. PubMed ID: 11696701
[TBL] [Abstract][Full Text] [Related]
7. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program.
Peters U; Chatterjee N; Church TR; Mayo C; Sturup S; Foster CB; Schatzkin A; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):315-20. PubMed ID: 16492922
[TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
[TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking and risk of prostate cancer in middle-aged men.
Plaskon LA; Penson DF; Vaughan TL; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):604-9. PubMed ID: 12869398
[TBL] [Abstract][Full Text] [Related]
10. Serum selenium level and prostate cancer: a case-control study.
Pourmand G; Salem S; Moradi K; Nikoobakht MR; Tajik P; Mehrsai A
Nutr Cancer; 2008; 60(2):171-6. PubMed ID: 18444148
[TBL] [Abstract][Full Text] [Related]
11. Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.
Vatten LJ; Ursin G; Ross RK; Stanczyk FZ; Lobo RA; Harvei S; Jellum E
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):967-9. PubMed ID: 9367072
[TBL] [Abstract][Full Text] [Related]
12. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.
Gann PH; Ma J; Hennekens CH; Hollis BW; Haddad JG; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):121-6. PubMed ID: 8850273
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
[TBL] [Abstract][Full Text] [Related]
14. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
[TBL] [Abstract][Full Text] [Related]
15. Obesity, adipokines, and prostate cancer in a prospective population-based study.
Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
[TBL] [Abstract][Full Text] [Related]
16. Smoking and colorectal cancer: different effects by type of cigarettes?
Lüchtenborg M; White KK; Wilkens L; Kolonel LN; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1341-7. PubMed ID: 17626999
[TBL] [Abstract][Full Text] [Related]
17. Relationship of serum uric acid to cancer occurrence in a prospective male cohort.
Kolonel LN; Yoshizawa C; Nomura AM; Stemmermann GN
Cancer Epidemiol Biomarkers Prev; 1994; 3(3):225-8. PubMed ID: 8019371
[TBL] [Abstract][Full Text] [Related]
18. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center.
Kurahashi N; Iwasaki M; Inoue M; Sasazuki S; Tsugane S
J Clin Oncol; 2008 Dec; 26(36):5923-9. PubMed ID: 19018085
[TBL] [Abstract][Full Text] [Related]
19. Obesity and the risk of prostate cancer.
Porter MP; Stanford JL
Prostate; 2005 Mar; 62(4):316-21. PubMed ID: 15389806
[TBL] [Abstract][Full Text] [Related]
20. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]